U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H15NO3
Molecular Weight 293.3166
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXAPROZIN

SMILES

OC(=O)CCC1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=OFPXSFXSNFPTHF-UHFFFAOYSA-N
InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)

HIDE SMILES / InChI
Molecular Formula C18H15NO3
Molecular Weight 293.3166
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
123738
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:43:44 UTC 2023
Edited
by admin
on Sat Dec 16 16:43:44 UTC 2023
Record UNII
MHJ80W9LRB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OXAPROZIN
HSDB   INN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN   INN  
Official Name English
OXAPROZIN [MART.]
Common Name English
4,5-DIPHENYL-2-OXAZOLEPROPANOIC ACID
Systematic Name English
OXAPROZIN [USP MONOGRAPH]
Common Name English
OXAPROZIN [JAN]
Common Name English
NSC-310839
Code English
COXANTO
Brand Name English
OXAPROZIN [USP-RS]
Common Name English
DAYPRO
Brand Name English
OXAPROZIN [HSDB]
Common Name English
OXAPROZIN [MI]
Common Name English
OXAPROZIN [VANDF]
Common Name English
OXAPROZIN [ORANGE BOOK]
Common Name English
WY-21743
Code English
2-OXAZOLEPROPANOIC ACID, 4,5-DIPHENYL-
Common Name English
WY-21,743
Code English
Oxaprozin [WHO-DD]
Common Name English
OXAPROZIN [USAN]
Common Name English
oxaprozin [INN]
Common Name English
Classification Tree Code System Code
WHO-ATC M01AE12
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
NDF-RT N0000000160
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
WHO-VATC QM01AE12
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
NDF-RT N0000175722
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
LIVERTOX NBK548334
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
NCI_THESAURUS C1323
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
NDF-RT N0000175721
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
Code System Code Type Description
DRUG CENTRAL
2013
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
WIKIPEDIA
Oxaprozin
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
DRUG BANK
DB00991
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
IUPHAR
7252
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
EPA CompTox
DTXSID1045118
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
MESH
C008729
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
ChEMBL
CHEMBL1071
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
EVMPD
SUB09502MIG
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
PUBCHEM
4614
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
CAS
21256-18-8
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
ECHA (EC/EINECS)
244-296-1
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
NCI_THESAURUS
C29307
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
HSDB
7586
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
MERCK INDEX
m8293
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY Merck Index
FDA UNII
MHJ80W9LRB
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
NSC
310839
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
RS_ITEM_NUM
1482207
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
RXCUI
32613
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY RxNorm
DAILYMED
MHJ80W9LRB
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
INN
3458
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
SMS_ID
100000092177
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
CHEBI
7822
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
LACTMED
Oxaprozin
Created by admin on Sat Dec 16 16:43:45 UTC 2023 , Edited by admin on Sat Dec 16 16:43:45 UTC 2023
PRIMARY
Related Record Type Details
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
COX-1
TARGET -> INHIBITOR
COX-2
TARGET -> INHIBITOR
Structure of OXAPROZIN POTASSIUM
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of OXAPROZIN GLUCURONIDE
METABOLITE -> PARENT
BILE
Structure of 4-(4-HYDROXYPHENYL)-5-PHENYL-2-OXAZOLEPROPANOIC ACID
METABOLITE -> PARENT
Structure of 4-(4-HYDROXYPHENYL)-5-PHENYL-2-OXAZOLEPROPANOIC ACID O-GLUCURONIDE
METABOLITE -> PARENT
Related Record Type Details
Structure of BENZOIN, (±)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of BENZOIN HEMISUCCINATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 2-[2-(4,5-Diphenyl-1,3-oxazol-2-yl)ethyl]-4,5-diphenyl-1,3-oxazole
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of OXAPROZIN IMIDAZOLE ANALOG
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of Tetraphenylpyrazine
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 4,5-Diphenyl-2-oxazolepropanamide
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of BENZIL
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
Structure of OXAPROZIN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966